Nanjing Vazyme Biotech Co., Ltd (SHA:688105)

Nanjing Vazyme Biotech Revenue

Nanjing Vazyme Biotech had revenue of 320.65M CNY in the quarter ending March 31, 2026, with 12.52% growth. This brings the company's revenue in the last twelve months to 1.41B, up 3.84% year-over-year. In the year 2025, Nanjing Vazyme Biotech had annual revenue of 1.38B.

• Revenue (ttm): 1.41B
• Revenue Growth: +3.84%
• P/S Ratio: 5.91
• Revenue / Employee: 493.04K
• Employees: 2,754
• Market Cap: 8.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.38B	-16.98K	-
Dec 31, 2024	1.38B	91.91M	7.15%
Dec 31, 2023	1.29B	-2.28B	-63.97%
Dec 31, 2022	3.57B	1.70B	90.99%
Dec 31, 2021	1.87B	304.17M	19.44%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error